Top news of the week: 04.03.2021.
Healthcare
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine
The FDA issued an EUA for the Janssen COVID-19 Vaccine, allowing the vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use - First Single-Shot Vaccine in Fight Against Global Pandemic
First Single-Shot Vaccine in Fight Against Global Pandemic
Natural History Data and the Path to Registration in Pediatric Rare Disease Research
As the clinical research industry experiences a growing focus on rare diseases, particularly on gene therapy approaches to rare, genetic disorders, the need for access to or collection of ...
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
This report describes the Advisory Committee on Immunization Practices’ (ACIP’s) interim recommendation for use of the Janssen COVID-19 vaccine for the prevention of COVID-19.
As Additional COVID Variants Surface, Questions Arise to Effectiveness of Vaccines to Combat New Strains
/PRNewswire/ -- The epic global race to solve the COVID-19 crisis has just gotten a be a more of a puzzle with the emergence of new variants. The existing...
8 Female Venture Capital Investors To Watch In 2021
A more inclusive VC industry means more opportunities for under-represented founders and more wealth for everyone. Here are eight female investors who are shaping the future of the venture ...
HealthTech For Care and EIT Health renew partnership for HealthTech Innovation Days and collaborate with BIO Deutschland
These partnerships, which reinforce the international dimension of the HealthTech Innovation Days, will facilitate collaborations within the European health ecosystem with the aim …
Sensyne Health gets approval for AI Covid test algorithm
British biotech company Sensyne Health has received regulatory approval in the UK for the first of a string of machine learning algorithms for Covid-19 risk prediction...